| |
|
Determine patient's aPTT ratio: To avoid initial overdosing, do not start REFLUDAN if aPTT ratio is >2.5 |
 |
|
Assess renal function: Determine baseline creatinine clearance or serum creatinine |
 |
|
REFLUDAN is dosed by weight up to 110 kg; patients >110 kg receive 110-kg dosage |
Initial Dose



|
IV bolus: 0.4 mg/kg |
 |
| |
| |
Administer bolus dose intravenously over 15 to 20 seconds |
 |
| |
Immediately following administration of bolus dose, begin REFLUDAN infusion |
| |
CAUTION: Preparation of REFLUDAN bolus injection requires dilution following reconstitution in order to obtain the final concentration of 5mg/mL |
|
 |
|
Continuous IV infusion: 0.15 mg/kg/hour, as long as clinically needed |
 |
| |
| |
Duration of therapy is generally 2 to 10 days |
|
 |
|
Simple dose adjustments when initiating therapy in patients with renal impairment |
To calculate appropriate dose, please use the REFLUDAN Dosing Calculator.
| Initial bolus dose provides rapid attainment of therapeutic levels (10 minutes) |
|



|
|